J. A. Engelman

Allelic dilution obscures detection of a biologically significant resistance mutation in EGFR-amplified lung cancer

J. A. Engelman, Toru Mukohara, Kreshnik Zejnullahu et al. · Journal of Clinical Investigation · 2006 · 457 citations · Full text

Engineering, Egfr-amplified Lung Cancer, Pathology +20

Implementing multiplexed genotyping of non-small-cell lung cancers into routine clinical practice

Lecia V. Sequist, Rebecca S. Heist, Alice T. Shaw et al. · Annals of Oncology · 2011 · 351 citations · Full text

Non-small-cell Lung Cancers, Cancer Detection, Medicine +11

EGFR mutation status and survival after diagnosis of brain metastasis in nonsmall cell lung cancer

April F. Eichler, Kristopher T. Kahle, D. L. Wang et al. · Neuro-Oncology · 2010 · 259 citations · Full text

Surgical Oncology, Cell Lung Cancer, Medicine +12

Identification of driver mutations in tumor specimens from 1,000 patients with lung adenocarcinoma: The NCI’s Lung Cancer Mutation Consortium (LCMC).

Mark G. Kris, B. E. Johnson, D J Kwiatkowski et al. · Journal of Clinical Oncology · 2011 · 213 citations

Surgical Oncology, Cancer Pathology, Cancer Management +18

Molecular mechanisms of resistance to first- and second-generation ALK inhibitors in ALK-rearranged lung cancer

Justin F. Gainor, Leila Dardaei, Satoshi Yoda et al. · European Journal of Cancer · 2016 · 195 citations

Oncology, Alk-rearranged Lung Cancer, Molecular Mechanisms +9